These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 429482)

  • 1. Comparative potency of subtilisin-cleaved and intact human growth hormone measured in growth hormone-deficient human subjects.
    Bunner DL; Lewis UJ; Vanderlaan WP
    J Clin Endocrinol Metab; 1979 Feb; 48(2):293-6. PubMed ID: 429482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness of growth hormone-deficient children to human growth hormone. Effect of replacement therapy for one year.
    Rudman D; Patterson JH; Gibbas DL
    J Clin Invest; 1973 May; 52(5):1108-12. PubMed ID: 4700485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement of growth hormone (GH) in normally growing GH-deficient patients operated for craniopharyngioma.
    Schoenle EJ; Zapf J; Prader A; Torresani T; Werder EA; Zachmann M
    J Clin Endocrinol Metab; 1995 Feb; 80(2):374-8. PubMed ID: 7852493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observations on the responsiveness of human subjects to human growth hormone. Effects of endogenous growth hormone deficiency and myotinic dystrophy.
    Rudman D; Chyatte SB; Patterson JH; Gerron GG; O'Beirne I; Barlow J; Ahmann P; Jordan A; Mosteller RC
    J Clin Invest; 1971 Sep; 50(9):1941-9. PubMed ID: 4327577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of the somatomedin C/insulin-like growth factor I: response to exogenous growth hormone (GH) in GH-deficient children.
    Blethen SL; Daughaday WH; Weldon VV
    J Clin Endocrinol Metab; 1982 May; 54(5):986-90. PubMed ID: 7037825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urea synthesis, nitrogen balance, and glucose turnover in growth-hormone-deficient children before and after growth hormone administration.
    Dahms WT; Owens RP; Kalhan SC; Kerr DS; Danish RK
    Metabolism; 1989 Mar; 38(3):197-203. PubMed ID: 2645501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a postreceptor site.
    Rosenfeld RG; Wilson DM; Dollar LA; Bennett A; Hintz RL
    J Clin Endocrinol Metab; 1982 May; 54(5):1033-8. PubMed ID: 7037819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic response to human growth hormone during prolonged starvation.
    Felig P; Marliss EB; Cahill GF
    J Clin Invest; 1971 Feb; 50(2):411-21. PubMed ID: 5540176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of various doses of biosynthetic growth hormone on levels of IGF-I binding protein 3 (IGFBP-3) in patients with hypopituitarism and growth hormone deficiency].
    Justová V; Lacinová Z; Marek J
    Sb Lek; 2002; 103(2):133-9. PubMed ID: 12688134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of human growth hormone administration on growth rate and growth-stimulating activity of serum, measured by lymphocyte bioassay in hypopituitary children.
    Bozzola M; Lorini R; Schimpff RM; Severi F; Job JC
    Horm Metab Res; 1986 Apr; 18(4):264-7. PubMed ID: 3710421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
    Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
    Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum profiles and short-term metabolic effect of pituitary and authentic biosynthetic human growth hormone in man. A double-blind cross-over study.
    Jørgensen JO; Flyvbjerg A; Dinesen J; Lund H; Alberti KG; Orskov H; Christiansen JS
    Acta Endocrinol (Copenh); 1987 Nov; 116(3):381-6. PubMed ID: 3318260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of the lipolytic potencies of pituitary-derived and biosynthetic human growth hormone in hypopituitary children.
    Van Vliet G; Bosson D; Craen M; Du Caju MV; Malvaux P; Vanderschueren-Lodeweyckx M
    J Clin Endocrinol Metab; 1987 Nov; 65(5):876-9. PubMed ID: 3667884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma growth hormone, insulin, and glucagon responses to arginine infusion in children and adolescents with idiopathic short stature, isolated growth hormone deficiency, panhypopituitarism, and anorexia nervosa.
    Sizonenko PC; Rabinovitch A; Schneider P; Paunier L; Wollheim CB; Zahnd G
    Pediatr Res; 1975 Sep; 9(9):733-8. PubMed ID: 1105371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant deoxyribonucleic acid-derived 22K- and 20K-human growth hormone generate equivalent diabetogenic effects during chronic infusion in dogs.
    Ader M; Agajanian T; Finegood DT; Bergman RN
    Endocrinology; 1987 Feb; 120(2):725-31. PubMed ID: 3542508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effect of animal prolactins and human growth hormone (HGH) in hypopituitary children.
    Blizzard RM; Drash AL; Jenkins ME; Spaulding JS; Glick A; Weldon VV; Powell GF; Raiti S
    J Clin Endocrinol Metab; 1966 Aug; 26(8):852-8. PubMed ID: 5921153
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperprolactinemia is associated with increased immunoreactive somatomedin C in hypopituitarism.
    Clemmons DR; Underwood LE; Ridgway EC; Kliman B; Van Wyk JJ
    J Clin Endocrinol Metab; 1981 Apr; 52(4):731-5. PubMed ID: 7193685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) treatment in short normal children: absence of influence of time of injection and resistance to GH autofeedback.
    Chanoine JP; Vanderschueren-Lodeweyckx M; Maes M; Thiry-Counson G; Craen M; Van Vliet G
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1269-75. PubMed ID: 1955508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that the N-terminus of human growth hormone is involved in expression of its growth promoting, diabetogenic, and insulin-like activities.
    Towns R; Kostyo JL; Vogel T; Sakal E; Tchelet A; Maher R; Gertler A
    Endocrinology; 1992 Mar; 130(3):1225-30. PubMed ID: 1537288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.